- Home
- WYY vs PULM Comparison
WYY vs PULM Comparison
Compare WYY & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- PULM
- Stock Information
- Founded
- WYY 1991
- PULM 2003
- Country
- WYY United States
- PULM United States
- Employees
- WYY N/A
- PULM N/A
- Industry
- WYY EDP Services
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- PULM Health Care
- Exchange
- WYY Nasdaq
- PULM Nasdaq
- Market Cap
- WYY 33.4M
- PULM 33.2M
- IPO Year
- WYY 1998
- PULM N/A
- Fundamental
- Price
- WYY $3.10
- PULM $7.43
- Analyst Decision
- WYY Strong Buy
- PULM
- Analyst Count
- WYY 1
- PULM 0
- Target Price
- WYY $7.00
- PULM N/A
- AVG Volume (30 Days)
- WYY 126.4K
- PULM 34.5K
- Earning Date
- WYY 08-13-2025
- PULM 08-12-2025
- Dividend Yield
- WYY N/A
- PULM N/A
- EPS Growth
- WYY N/A
- PULM N/A
- EPS
- WYY N/A
- PULM N/A
- Revenue
- WYY $142,582,209.00
- PULM $1,921,000.00
- Revenue This Year
- WYY $10.84
- PULM N/A
- Revenue Next Year
- WYY $12.37
- PULM $134.88
- P/E Ratio
- WYY N/A
- PULM N/A
- Revenue Growth
- WYY 24.03
- PULM N/A
- 52 Week Low
- WYY $2.19
- PULM $1.78
- 52 Week High
- WYY $6.25
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- WYY 40.97
- PULM 49.28
- Support Level
- WYY $3.01
- PULM $8.49
- Resistance Level
- WYY $3.41
- PULM $8.75
- Average True Range (ATR)
- WYY 0.27
- PULM 0.42
- MACD
- WYY -0.02
- PULM -0.14
- Stochastic Oscillator
- WYY 7.53
- PULM 0.11
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).